Although no studies have yet explored the consequences of disrupted cardiac ATG7 expression, familial ATG5 mutations are associated with severe cardiac hypertrophy leading to dilated cardiomyopathy by 10 months [55]. This evidence concerns the gene ATG7 and dilated cardiomyopathy.